Cytosorbents Corporation (CTSO)
NASDAQ · Healthcare
Cytosorbents Corporation Revenue 2011–2025
Cytosorbents Corporation annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cytosorbents Corporation revenue for the quarter ending March 31, 2026 was 8.9 M, a 1.57% increase year-over-year.
- Cytosorbents Corporation revenue for the twelve months ending March 31, 2026 was 36.7 M, a 4.08% increase year-over-year.
- Cytosorbents Corporation annual revenue for 2025 was 37.1 M, a 4.12% increase from 2024.
- Cytosorbents Corporation annual revenue for 2024 was 35.6 M, a 14.51% increase from 2023.
- Cytosorbents Corporation annual revenue for 2023 was 31.1 M, a 10.39% decrease from 2022.
- Cytosorbents Corporation annual revenue for 2022 was 34.7 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cytosorbents Corporation Market Cap — FAQ
Cytosorbents Corporation (CTSO) market cap over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTSO's market cap history?
The chart and table above show Cytosorbents Corporation's market cap by year and by quarter, including the growth rate.